Joachim Maus

1.5k total citations
20 papers, 935 citations indexed

About

Joachim Maus is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Joachim Maus has authored 20 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology and Allergy. Recurrent topics in Joachim Maus's work include Asthma and respiratory diseases (14 papers), Inhalation and Respiratory Drug Delivery (9 papers) and Respiratory and Cough-Related Research (8 papers). Joachim Maus is often cited by papers focused on Asthma and respiratory diseases (14 papers), Inhalation and Respiratory Drug Delivery (9 papers) and Respiratory and Cough-Related Research (8 papers). Joachim Maus collaborates with scholars based in Germany, United States and Belgium. Joachim Maus's co-authors include Ullrich Munzel, Phillip A. Low, P. James B. Dyck, Dan Ziegler, Р. Р. Самигуллин, Ametov As, N. N. Yakhno, Irina Gurieva, Maria Novosadova and Itamar Raz and has published in prestigious journals such as Diabetes Care, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Joachim Maus

19 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joachim Maus Germany 10 493 337 234 164 147 20 935
Ametov As Russia 10 482 1.0× 379 1.1× 294 1.3× 199 1.2× 50 0.3× 149 1.1k
H. Nowak Germany 6 221 0.4× 241 0.7× 230 1.0× 82 0.5× 48 0.3× 14 536
Ehsan Dadgostar Iran 17 193 0.4× 166 0.5× 32 0.1× 251 1.5× 38 0.3× 47 908
F Kristek Slovakia 22 594 1.2× 147 0.4× 413 1.8× 239 1.5× 61 0.4× 68 1.3k
Р. Р. Самигуллин Russia 5 562 1.1× 505 1.5× 344 1.5× 146 0.9× 29 0.2× 11 996
Mary E. Maley United States 13 195 0.4× 122 0.4× 107 0.5× 156 1.0× 85 0.6× 14 769
Kotaro Kida United States 17 212 0.4× 91 0.3× 365 1.6× 232 1.4× 69 0.5× 24 987
Eun‐Jeong Koh South Korea 17 131 0.3× 267 0.8× 20 0.1× 194 1.2× 31 0.2× 53 850

Countries citing papers authored by Joachim Maus

Since Specialization
Citations

This map shows the geographic impact of Joachim Maus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Maus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Maus more than expected).

Fields of papers citing papers by Joachim Maus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Maus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Maus. The network helps show where Joachim Maus may publish in the future.

Co-authorship network of co-authors of Joachim Maus

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Maus. A scholar is included among the top collaborators of Joachim Maus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Maus. Joachim Maus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Derendorf, Hartmut, Ullrich Munzel, Joachim Maus, et al.. (2012). Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29‐02, a novel aqueous nasal spray. British Journal of Clinical Pharmacology. 74(1). 125–133. 28 indexed citations
5.
Voshaar, Thomas, et al.. (2012). A retrospective database analysis on persistence with inhaled corticosteroid therapy: comparison of two dry powder inhalers during asthma treatment in Germany. International Journal of Clinical Pharmacology and Therapeutics. 50(4). 257–264. 8 indexed citations
6.
Ziegler, Dan, Phillip A. Low, William J. Litchy, et al.. (2011). Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy. Diabetes Care. 34(9). 2054–2060. 261 indexed citations
7.
8.
Gollnick, Harald, Carlos Guillén Barona, Thomas Ruzicka, et al.. (2009). Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe.. PubMed. 18(6). 677–82. 81 indexed citations
9.
Stockfleth, Eggert, et al.. (2009). Treatment of multiple, multiform actinic keratoses on the head with imiquimod 5% cream. European Journal of Dermatology. 19(4). 355–359. 9 indexed citations
10.
Nguyen, Duc Tung, et al.. (2008). Single-Dose Pharmacokinetics and Safety Pharmacodynamics of Formoterol Delivered by Two Different Dry Powder Inhalers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21(3). 309–320. 4 indexed citations
11.
Bauhofer, Artur, et al.. (2008). Synergistic Bronchodilatory Effects of Dexpirronium and Formoterol in Guinea Pigs. Journal of Allergy and Clinical Immunology. 121(2). S8–S9. 2 indexed citations
12.
Berg, Andrea von, et al.. (2007). Peak Inspiratory Flow Rates Generated through The Novolizer ® And The Turbuhaler ® Dry Powder Inhaler Devices by Children with Stable Asthma. Journal of Aerosol Medicine. 20(1). 50–58. 11 indexed citations
13.
Hermann, Róbert, Jürgen Borlak, Ullrich Munzel, et al.. (2006). The role of Gilbert's syndrome and frequent NAT2 slow acetylation polymorphisms in the pharmacokinetics of retigabine. The Pharmacogenomics Journal. 6(3). 211–219. 15 indexed citations
14.
Richter, Kai, et al.. (2006). Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthma. Pulmonary Pharmacology & Therapeutics. 21(1). 61–66. 7 indexed citations
15.
Pahl, Andreas, et al.. (2006). Synergistic effects of the anti-cholinergic R,R-glycopyrrolate with anti-inflammatory drugs. Biochemical Pharmacology. 72(12). 1690–1696. 23 indexed citations
16.
17.
Ziegler, Dan, Ametov As, P. James B. Dyck, et al.. (2006). Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy. Diabetes Care. 29(11). 2365–2370. 380 indexed citations
18.
Nowak, Horst, et al.. (2005). Tramadol SR Formulations. Clinical Drug Investigation. 25(7). 435–443. 14 indexed citations
19.
Hansel, Trevor T., Helen Neighbour, Edward M. Erin, et al.. (2005). Glycopyrrolate Causes Prolonged Bronchoprotection and Bronchodilatation in Patients With Asthma. CHEST Journal. 128(4). 1974–1979. 52 indexed citations
20.
Vogelberg, Christian, et al.. (2004). Clinical evaluation of the peak inspiratory flow generated by asthmatic children through the Novolizer®. Respiratory Medicine. 98(10). 924–931. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ametov As Breakdown of academic impact, for papers by H. Nowak Breakdown of academic impact, for papers by Ehsan Dadgostar Breakdown of academic impact, for papers by F Kristek Breakdown of academic impact, for papers by Р. Р. Самигуллин Breakdown of academic impact, for papers by Mary E. Maley Breakdown of academic impact, for papers by Kotaro Kida Breakdown of academic impact, for papers by Eun‐Jeong Koh
Rankless by CCL
2026